BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Breckenridge Pharmaceutical, Inc. 

1141 S. Rogers Circle
Suite 3
Boca Raton  Florida  33487  U.S.A.
Phone: 800-367-3395 Fax: 561-989-9747


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014 8:59:59 AM
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation With Novartis AG (NVS) For Its ANDA Everolimus Oral Tablets (Zortress®) 9/5/2014 10:32:31 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Duloxetine Delayed-Release Capsules 6/13/2014 10:48:04 AM
Pernix Therapeutics, Inc. (PTX) Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc. 9/12/2013 10:06:56 AM
Breckenridge Pharmaceutical, Inc. Completes Acquisition of Certain Cypress Products From Pernix Therapeutics, Inc. (PTX) 9/12/2013 9:10:13 AM
Breckenridge Pharmaceutical, Inc. Buys Certain Cypress Pharmaceutical Assets From Pernix Therapeutics, Inc. (PTX) for $30 Million 8/9/2013 6:40:51 AM
Breckenridge Pharmaceutical, Inc. Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products 7/10/2013 8:54:55 AM
Breckenridge Pharmaceutical, Inc. Announces Approval of Rizatriptan Benzoate ODT (Orally Disintegrating Tablets) 7/3/2013 10:50:59 AM
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Par Pharmaceutical, Inc. & Alkermes Pharma Ireland Limited for Its ANDA Megestrol Acetate Oral Suspension (Megace® ES) 6/28/2013 10:27:14 AM
Breckenridge Pharmaceutical, Inc. Signs Letter of Intent With Welding GmbH & Co & SK Chemicals 6/11/2013 8:30:17 AM
12345